Still, the results showed that when DPP7 expression in tumor cells was elevated, the cytotoxic function of activated Jurkat cells was inhibited, leading to decreased secretion of the immune cytotoxicity marker IL-2 on the one hand, and decreased viability of Jurkat cells on the other hand. The gene discussed is DPP7; the disease is neoplasm.